DK3737402T5 - Modificeret protein - Google Patents
Modificeret protein Download PDFInfo
- Publication number
- DK3737402T5 DK3737402T5 DK19700991.3T DK19700991T DK3737402T5 DK 3737402 T5 DK3737402 T5 DK 3737402T5 DK 19700991 T DK19700991 T DK 19700991T DK 3737402 T5 DK3737402 T5 DK 3737402T5
- Authority
- DK
- Denmark
- Prior art keywords
- modified protein
- protein
- modified
- Prior art date
Links
- 102000035118 modified proteins Human genes 0.000 title 1
- 108091005573 modified proteins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1800334.3A GB201800334D0 (en) | 2018-01-09 | 2018-01-09 | Modified protein |
| PCT/GB2019/050053 WO2019138222A1 (en) | 2018-01-09 | 2019-01-09 | Modified protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3737402T3 DK3737402T3 (en) | 2023-04-17 |
| DK3737402T5 true DK3737402T5 (da) | 2024-08-26 |
Family
ID=61190345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19700991.3T DK3737402T5 (da) | 2018-01-09 | 2019-01-09 | Modificeret protein |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11466059B2 (da) |
| EP (2) | EP3737402B1 (da) |
| JP (2) | JP7532251B2 (da) |
| KR (1) | KR20200108031A (da) |
| CN (1) | CN111818936A (da) |
| CA (1) | CA3087835A1 (da) |
| DK (1) | DK3737402T5 (da) |
| ES (1) | ES2942318T3 (da) |
| GB (1) | GB201800334D0 (da) |
| WO (1) | WO2019138222A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201800334D0 (en) * | 2018-01-09 | 2018-02-21 | Pneumagen Ltd | Modified protein |
| GB201803197D0 (en) | 2018-02-27 | 2018-04-11 | Pneumagen Ltd | Viral treatment |
| GB201819920D0 (en) * | 2018-12-06 | 2019-01-23 | Pneumagen Ltd | Cancer treatment |
| GB201901057D0 (en) | 2019-01-25 | 2019-03-13 | Pneumagen Ltd | Cbm uses |
| GB201912365D0 (en) * | 2019-08-28 | 2019-10-09 | Pneumagen Ltd | Treatment |
| WO2021176017A1 (en) * | 2020-03-05 | 2021-09-10 | Pneumagen Ltd | Treatment of viral infection |
| WO2024081906A1 (en) * | 2022-10-14 | 2024-04-18 | The Children's Medical Center Corporation | A maps vaccine targeting group b streptococcus (gbs) |
| GB202315114D0 (en) * | 2023-10-02 | 2023-11-15 | Pneumagen Ltd | Viral treatment |
| GB202418737D0 (en) * | 2024-12-19 | 2025-02-05 | Pneumagen Ltd | Conjugate molecules |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2344196B1 (en) | 2008-09-12 | 2018-11-14 | University Court of The University of St Andrews | Carbohydrate binding molecules |
| CA2937840C (en) * | 2014-01-24 | 2022-02-15 | Garry Taylor | Immunomodulatory compounds |
| GB201616006D0 (en) | 2016-09-20 | 2016-11-02 | Univ Court Of The Univ Of St Andrews The | Cell modulation |
| GB201616007D0 (en) | 2016-09-20 | 2016-11-02 | Univ Court Of The Univ Of St Andrews The | Novel Adjuvants |
| GB201616009D0 (en) | 2016-09-20 | 2016-11-02 | Univ Court Of The Univ Of St Andrews The | Treatment and/or prevention of sepsis |
| GB201800334D0 (en) * | 2018-01-09 | 2018-02-21 | Pneumagen Ltd | Modified protein |
-
2018
- 2018-01-09 GB GBGB1800334.3A patent/GB201800334D0/en not_active Ceased
-
2019
- 2019-01-09 WO PCT/GB2019/050053 patent/WO2019138222A1/en not_active Ceased
- 2019-01-09 JP JP2020538906A patent/JP7532251B2/ja active Active
- 2019-01-09 EP EP19700991.3A patent/EP3737402B1/en active Active
- 2019-01-09 US US15/733,350 patent/US11466059B2/en active Active
- 2019-01-09 EP EP23161597.2A patent/EP4233888A3/en active Pending
- 2019-01-09 ES ES19700991T patent/ES2942318T3/es active Active
- 2019-01-09 KR KR1020207022938A patent/KR20200108031A/ko active Pending
- 2019-01-09 DK DK19700991.3T patent/DK3737402T5/da active
- 2019-01-09 CA CA3087835A patent/CA3087835A1/en active Pending
- 2019-01-09 CN CN201980016788.6A patent/CN111818936A/zh active Pending
-
2022
- 2022-09-06 US US17/929,862 patent/US20230036052A1/en active Pending
-
2024
- 2024-07-31 JP JP2024124909A patent/JP2024163117A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111818936A (zh) | 2020-10-23 |
| ES2942318T3 (es) | 2023-05-31 |
| JP7532251B2 (ja) | 2024-08-13 |
| CA3087835A1 (en) | 2019-07-18 |
| US20230036052A1 (en) | 2023-02-02 |
| EP4233888A2 (en) | 2023-08-30 |
| EP4233888A3 (en) | 2023-10-25 |
| JP2021511308A (ja) | 2021-05-06 |
| DK3737402T3 (en) | 2023-04-17 |
| JP2024163117A (ja) | 2024-11-21 |
| US20210070814A1 (en) | 2021-03-11 |
| US11466059B2 (en) | 2022-10-11 |
| EP3737402B1 (en) | 2023-03-15 |
| WO2019138222A1 (en) | 2019-07-18 |
| GB201800334D0 (en) | 2018-02-21 |
| EP3737402A1 (en) | 2020-11-18 |
| KR20200108031A (ko) | 2020-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3801265B1 (en) | URINARY FLOWMETER | |
| FIC20253006I1 (fi) | Linvoseltamabi | |
| EP3890716A4 (en) | COMBINATION THERAPIES | |
| EP3849534A4 (en) | COMBINATION THERAPIES | |
| EP3846674C0 (en) | VAGINAL SPECULUM | |
| EP3555124C0 (en) | TCR NYESO | |
| IL281804A (en) | Protein purification methods | |
| MA53616A (fr) | Protéines bispécifiques modifiées | |
| DK3737403T3 (da) | Modificerede adenovira | |
| EP3781060A4 (en) | CRYOPROBE | |
| EP3872558A4 (en) | OPTICAL ISOLATOR | |
| EP3784463A4 (en) | Fluorosulfones | |
| EP3810860C0 (en) | COUPLER | |
| GB201800334D0 (en) | Modified protein | |
| EP3792200A4 (en) | TANK TANK | |
| EP3878374A4 (en) | OKKLUDER | |
| EP3721129C0 (en) | Cryosphere | |
| EP3740501A4 (en) | FUSION PROTEIN EXTENSIONS | |
| EP3609527C0 (en) | PROTEIN CONJUGATES | |
| EP3844177A4 (en) | COMBINATION THERAPIES | |
| DK3587968T3 (da) | Fluidsystem | |
| DK3752258T3 (da) | Trampolin | |
| EP3647426A4 (en) | FUSION PROTEIN | |
| PL3880011T3 (pl) | Sposób | |
| DK3837273T3 (da) | Forbedret proteingenvinding |